1.
Bioorg Med Chem Lett
; 16(18): 4965-8, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16806919
RESUMO
A series of 4,5-disubstituted cis-pyrrolidinones was investigated as inhibitors of 17beta-HSD II for the treatment of osteoporosis. Biochemical data for several compounds are given. Compound 42 was selected as the lead candidate.